Bio-Pharmaceutical Industry R & D Performance Study in China
DOI: 10.23977/acccm.2021.030107 | Downloads: 32 | Views: 962
Author(s)
Jian Yu 1
Affiliation(s)
1 College of Business Administration, Jiangxi University of Finance and Economics, Nanchang, P.R.C.
Corresponding Author
Jian YuABSTRACT
Bio pharmaceutical industry is a resource-conserving and environment-friendly industry, which is still a new industry in the world. In the process of the development of bio pharmaceutical industry in China, the advantage is the raw material procurement and marketing, the disadvantage is research and development. There are four problems in the research and development of biological medicine industry in China: The shortage of funds, the lack of compound talents, the single source of funds, and the slow development of scientific research. The two models show that the research and development of biological medicine industry in China will have a lagging effect on the development of China's pharmaceutical industry. Four suggestions are put forward: to improve the policy of biological medicine industry, to build a platform for enterprises, to improve the capital market and to train high quality talents.
KEYWORDS
Bio pharmaceutical, R & D investment, Emerging industriesCITE THIS PAPER
Jian Yu. Bio-Pharmaceutical Industry R & D Performance Study in China. Accounting and Corporate Management (2021) 3: 42-54. DOI: http://dx.doi.org/10.23977/acccm.2021.030107.
REFERENCES
[1] Wan, F. (2012). Measurement of industrial agglomeration: innovation based on the empirical research on biological medicine industry in China. (05).
[2] Ye, L. and Feng, G.Z. (2011). Empirical analysis of R & amp; D input and output in China's pharmaceutical industry. modern commercial industry, (19).
[3] Niosi, J., Hanel, P. and Reid, S. (2012). The international diffusion of biotechnology: the arrival of developing countries. Journal of Evolutionary Economics, (4).
[4] Bianchi, M., Cavaliere, A., Chiaroni, D., Frattini, F. and Chiesa, V. (2010). Organisational modes for Open Innovation in the bio-pharmaceutical industry: An exploratory analysis. Technovation, (1).
[5] Calero, C., Leeuwen, T.N. and Tijssen, R.J.W. (2007). Research cooperation within the bio-pharmaceutical industry: Network analyses of co-publications within and between firms. Scientometrics, (1).
[6] Moschini, G. (2006). Pharmaceuticals and Industrial Traits in Genetically Modified Crops: Coexistence with Conventional Agriculture. American Journal of Agricultural Economics, 88(5).
[7] Bianchi, T.S, Allison, M.A. (2009). Large-river delta-front estuaries as natural "recorders" of global environmental change. Proceedings of the National Academy of Sciences, 106(20), 8085-8092.
[8] Lynn, K. and Mytelka. (2006). Pathways and Policies to (Bio) Pharmaceutical Innovation Systems in Developing Countries. Industry & Innovation, (4).
[9] Linda, A.H. and Sharmistha, B.S. (2006). An analysis of firm-level innovation strategies in the US biotechnology industry. Technovation, (1).
[10] Kneller, R. (2003). Autarkic drug discovery in Japanese pharmaceutical companies: insights into national differences in industrial innovation. Research Policy, (10).
[11] Orsenigo, L., Pammolli, F. and Riccaboni, M. (2001). Technological change and network dynamics. Research Policy, (3).
Downloads: | 11425 |
---|---|
Visits: | 164562 |
Sponsors, Associates, and Links
-
Information Systems and Economics
-
Accounting, Auditing and Finance
-
Industrial Engineering and Innovation Management
-
Tourism Management and Technology Economy
-
Journal of Computational and Financial Econometrics
-
Financial Engineering and Risk Management
-
Social Security and Administration Management
-
Population, Resources & Environmental Economics
-
Statistics & Quantitative Economics
-
Agricultural & Forestry Economics and Management
-
Social Medicine and Health Management
-
Land Resource Management
-
Information, Library and Archival Science
-
Journal of Human Resource Development
-
Manufacturing and Service Operations Management
-
Operational Research and Cybernetics